MRFIX
Price
$61.20
Change
+$0.55 (+0.91%)
Updated
Jun 6 closing price
Net Assets
7.91B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

MRFIX vs VITSX

Header iconMRFIX vs VITSX Comparison
Open Charts MRFIX vs VITSXBanner chart's image
MFS Research I
Price$61.20
Change+$0.55 (+0.91%)
VolumeN/A
Net Assets7.91B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
MRFIX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRFIX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRFIX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. MRFIX (7.91B). VITSX pays higher dividends than MRFIX: VITSX (1.29) vs MRFIX (0.69). MRFIX was incepted earlier than VITSX: MRFIX (28 years) vs VITSX (28 years). MRFIX (0.52) is less costly to investors than VITSX (0.03). MRFIX is a more actively managed with annual turnover of: 24.00 vs. VITSX (2.00). MRFIX has a lower initial minimum investment than VITSX: MRFIX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. MRFIX (-0.09). VITSX return over 5 years is better than : 80.96 vs. MRFIX (31.07).
MRFIXVITSXMRFIX / VITSX
Total Expense Ratio0.520.031,733%
Annual Report Gross Expense Ratio0.520.031,733%
Fund Existence28 years28 years-
Gain YTD1.0330.833124%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.91B1.82T0%
Annual Yield % from dividends0.691.2954%
Returns for 1 year-0.0910.97-1%
Returns for 3 years12.0240.3530%
Returns for 5 years31.0780.9638%
Returns for 10 years60.20180.4933%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.